FOR IMMEDIATE RELEASE
Media Contact: Michael Tetreault, Editor | Tel. (770) 455-1650 ext 151 | editor@ConciergeMedicineToday.com
A new partnership equips Concierge Medicine and Direct Primary Care physicians with the most comprehensive pharmacogenomics testing, PGxOne™ Plus, allowing physicians to predict how patients will respond to drug therapy based on their individual genetic makeup.
NOVEMBER 15, 2016 | South Plainfield, NJ – Molecular Diagnostics company Admera Health and Concierge Medicine Today (CMT), the premier publication in Concierge Medicine, announced a partnership to provide the simple, cost-effective, one-time pharmacogenomics test, PGxOneTM Plus. PGxOneTM Plus results can help predict how patients will respond to drug therapy for eleven therapeutic areas including psychiatry, pain management and cardiology.
Leveraging Next Generation Sequencing (NGS) technology, this expanded 50-gene panel can detect nearly 200 different variants and provides recommendations for over 220 associated drugs. The recommendations include considering alternatives when specific drugs should be avoided, dosage adjustment information when available, use with caution, and normal response expected. The PGxOne™ Plus report also provides information related to drug-to-drug, drug-to-food, drug-to-alcohol and drug-to-laboratory test interactions that are relevant to a patient’s current medications. Thus, test results offer physicians a valuable tool for guiding effective treatment decisions and potentially reducing trial-and-error treatment selection and adverse drug events.
“Admera Health seeks to redefine disease screening, diagnosis, treatment, monitoring, and management through its innovative, personalized solutions and understands that Concierge Medicine is the ideal mechanism for delivering the industry’s most comprehensive pharmacogenomics test,” said Brady Millican, Vice President, Admera Health. “We are excited about the opportunity to facilitate and administer the PGxOne Plus test program, working with Admera Health and partnering with Concierge Medicine Today as we support the Concierge Physicians they serve,” stated Jeff Knapp, Managing Partner, Next Health Solutions, LLC.
Concierge Medicine Today issued a statement of support recently for the use and appropriate application of pharmacogenomics testing under the guidance and direction of a physician.
“What would happen if physicians could begin making treatment recommendations based upon a patient’s genotype?” said Catherine Sykes, CEO/Publisher of Concierge Medicine Today. “Concierge Doctors are in the habit of spending an inordinate amount of time with their patients, many of whom have significant and serious health issues. What would happen if we intentionally connected [Concierge] physicians with new scientific technologies that could enable them to deliver better precision treatment recommendations and provide more accurate prescribing to their patients? We aim to find out.”
“Pharmacogenomics is vanguard science which allows physicians to target an individual with the very best personalized therapy based on their own genetic information,” said Zeil Rosenberg, M.D., Vice President, Medical Affairs, Admera Health. “Thanks to major advances in medicine and information by patients, this knowledge translates into clear and immediate clinical benefits.”
“This is an important next step in medicine,” said Sykes. “It is critical that patients and their advising physician(s) begin to learn more about a person’s individual genome. Medical science is advancing more rapidly than we’ve ever seen, outpacing what a physician can possibly know about adverse drug interactions based on genotype. There are tests available and becoming increasingly more affordable that determine how patients will respond to drug therapy for a number of therapeutic areas, including psychiatry, pain management and cardiology.”
Patients need only to be tested once, as genetic information does not change over time. Therefore, these results have lifetime utility. As hospitals implement clinical pharmacogenomics testing programs in the coming years, more physicians will be able to utilize this valuable information to guide drug management and provide better patient care.
About Admera Health
Admera Health is an advanced molecular diagnostics company focused on personalized medicine, non-invasive cancer testing and digital health. Dedicated to developing cutting-edge diagnostics that span the continuum of care, Admera Health fulfills unmet medical needs with cost-effective tests and accurate analysis to guide patient care. Utilizing next generation technology platforms and advanced bioinformatics, Admera Health seeks to redefine disease screening, diagnosis, treatment, monitoring, and management through its innovative, personalized solutions. Frost and Sullivan recognized Admera Health with the 2016 North American Award for Technology Innovation. Admera Health was recently profiled on Worldwide Business with Kathy Ireland®. Watch the interview by clicking here.
About Concierge Medicine Today
Concierge Medicine Today (CMT) is a news organization and the Concierge Medicine industry’s oldest national trade publication for the Concierge Medicine and Membership Medicine marketplace. Its web site is the online destination for businesses, consumers, physicians, legislators, researchers and other stakeholders to learn about the history of this industry, various business aspects of the marketplace, trends, breaking news and more that drives the conversation that Concierge Medicine and free market healthcare delivery is creating on a national and international level. For more information, visit: http://www.ConciergeMedicineToday.org